From: Impairment of alternative splice sites defining a novel gammaretroviral exon within gagmodifies the oncogenic properties of Akv murine leukemia virus
Virus
Average latency period (days)
Frequency of mice developing hematopoitic tumors
Akv-wt
184 ± 26
40/40
Akv-CD
201 ± 30
17/19
Akv-EH
184 ± 34
17/18
Akv-CDH
190 ± 46
14/16